Search results
Results from the WOW.Com Content Network
In July 2022, the Canadian generic drug company, Apotex Inc., obtained approval for marketing of apixaban. [37] [38] Pfizer reported revenue of US$6.747 billion for Eliquis in 2023. [39] Apixaban is one of ten medications covered by price negotiations in the US under the Inflation Reduction Act.
30 20-25: 1–1.5: 40–250: ... Drug Name Common Trade Names Year ... This chart contains binding data for benzodiazepines and related drugs investigated by Roche up ...
Vyvanse (lisdexamfetamine) – a pro-drug stimulant used to treat attention deficit hyperactivity disorder and binge eating disorder; Vyvanse is converted into Dexedrine in vivo; Viibryd – an antidepressant of the serotonin modulator and stimulators class; Vivactil (protriptyline) an antidepressant also used in the treatment of nerve pain
The over 250 drug hikes represent an increase from Dec. 29 last year when drugmakers unveiled plans to raise prices on more than 140 brands of drugs. Drug companies are also reducing some prices ...
One of the common causes for people existing across the political aisle is the cost of prescription drugs. In fact, one study published by JAMA indicated that roughly 79 percent of surveyed...
The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries. Some medications treat multiple conditions and appear multiple times.
After adjusting for changes in drug costs between 2020 and 2022, the researchers found that Medicare paid more on 77 generic drugs: $8.1 billion compared with $4.5 billion if Medicare had ...
Drug Main indication Trade name 2018 sales (million USD) 2017 sales (million USD) 1 adalimumab: rheumatoid arthritis: Humira 19 936 18427 3 apixaban: anticoagulant: Eliquis 9872 7395 4 lenalidomide: multiple myeloma: Revlimid 9685 8187 5 nivolumab: oncology: Opdivo 7570 5763 6 pembrolizumab: oncology: Keytruda 7171 3809 7 etanercept: rheumatoid ...